{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T04:56:50Z","timestamp":1794200210672,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T00:00:00Z","timestamp":1467676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s10194-016-0651-8","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T18:42:01Z","timestamp":1467657721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"17","author":[{"given":"Mostafa Ebraheem","family":"Morra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elgebaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elmaraezy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham M.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M. A.","family":"Altibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Le-Huy","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Reda","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9543-9440","authenticated-orcid":false,"given":"Nguyen Tien","family":"Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,5]]},"reference":[{"key":"651_CR1","doi-asserted-by":"crossref","unstructured":"Devor M, Wood I, Sharav Y, Zakrzewska JM (2008) Trigeminal neuralgia during sleep. Pain Pract 8(4):263\u20138. http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1533-2500.2008.00214.x\/full","DOI":"10.1111\/j.1533-2500.2008.00214.x"},{"issue":"4","key":"651_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.sjpain.2011.08.003","volume":"2","author":"EKB Hals","year":"2011","unstructured":"Hals EKB, Stubhaug A (2011) Mental and somatic co-morbidities in chronic orofacial pain conditions: Pain patients in need of multiprofessional team approach. Scand J Pain 2(4):153\u2013154","journal-title":"Scand. J. Pain"},{"key":"651_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1129-2377-14-37","volume":"14","author":"JM Zakrzewska","year":"2013","unstructured":"Zakrzewska JM (2013) Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain 14:37","journal-title":"J. Headache Pain"},{"issue":"2A","key":"651_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1590\/S0004-282X2011000200016","volume":"69","author":"WK Campos","year":"2011","unstructured":"Campos WK, Linhares MN (2011) A prospective study of 39 patients with trigeminal neuralgia treated with percutaneous balloon compression. Arq Neuropsiquiatr 69(2A):221\u20136","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1028","key":"651_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/pgmj.2009.080473","volume":"87","author":"JM Zakrzewska","year":"2011","unstructured":"Zakrzewska JM, McMillan R (2011) Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain. Postgrad Med J 87(1028):410\u20136","journal-title":"Postgrad. Med. J."},{"key":"651_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s10194-015-0548-y","volume":"16","author":"T-H Wu","year":"2015","unstructured":"Wu T-H, Hu L-Y, Lu T, Chen P-M, Chen H-J, Shen C-C, Wen C-H (2015) Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study. J Headache Pain 16:64","journal-title":"J. Headache Pain"},{"issue":"3","key":"651_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.mehy.2009.09.056","volume":"74","author":"D Jia","year":"2010","unstructured":"Jia D, Li G (2010) Bioresonance hypothesis: a new mechanism on the pathogenesis of trigeminal neuralgia. Med Hypotheses 74(3):505\u20137","journal-title":"Med. Hypotheses"},{"issue":"11","key":"651_CR8","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1586\/ern.11.156","volume":"11","author":"M Obermann","year":"2011","unstructured":"Obermann M, Holle D, Katsarava Z (2011) Trigeminal neuralgia and persistent idiopathic facial pain. Expert Rev Neurother 11(11):1619\u201329","journal-title":"Expert Rev. Neurother."},{"issue":"10","key":"651_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","volume":"15","author":"G Cruccu","year":"2008","unstructured":"Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM (2008) AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 15(10):1013\u201328","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"651_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40263-012-0023-0","volume":"27","author":"G Cruccu","year":"2013","unstructured":"Cruccu G, Truini A (2013) Refractory trigeminal neuralgia. Non-surgical treatment options. CNS Drugs 27(2):91\u20136","journal-title":"CNS Drugs"},{"issue":"3","key":"651_CR11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/SCS.0b013e31821a07b7","volume":"22","author":"PS Chakravarthi","year":"2011","unstructured":"Chakravarthi PS, Ghanta R, Kattimani V (2011) Microvascular decompression treatment for trigeminal neuralgia. J Craniofac Surg 22(3):894\u2013898","journal-title":"J. Craniofac. Surg."},{"issue":"8","key":"651_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00701-011-1026-1","volume":"153","author":"K-J Park","year":"2011","unstructured":"Park K-J, Kano H, Berkowitz O, Awan NR, Flickinger JC, Lunsford LD, Kondziolka D (2011) Computed tomography-guided \u03b3 knife stereotactic radiosurgery for trigeminal neuralgia. Acta Neurochir (Wien) 153(8):1601\u20131609","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"651_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.pain.2010.10.049","volume":"152","author":"JSHA Koopman","year":"2011","unstructured":"Koopman JSHA, De Vries LM, Dieleman JP, Huygen FJ, Stricker BHC, Sturkenboom MCJM (2011) A nationwide study of three invasive treatments for trigeminal neuralgia. Pain 152(3):507\u2013513","journal-title":"Pain"},{"issue":"663","key":"651_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/pgmj.57.663.16","volume":"57","author":"JC Taylor","year":"1981","unstructured":"Taylor JC, Brauer S, Espir ML (1981) Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J 57(663):16\u20138","journal-title":"Postgrad. Med. J."},{"issue":"1","key":"651_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1042-3680(18)30335-8","volume":"8","author":"JM Taha","year":"1997","unstructured":"Taha JM, Tew JM (1997) Treatment of trigeminal neuralgia by percutaneous radiofrequency rhizotomy. Neurosurg Clin N Am 8(1):31\u20139","journal-title":"Neurosurg. Clin. N. Am."},{"key":"651_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s10194-015-0550-4","volume":"16","author":"T Heinskou","year":"2015","unstructured":"Heinskou T, Maarbjerg S, Rochat P, Wolfram F, Jensen RH, Bendtsen L (2015) Trigeminal neuralgia--a coherent cross-specialty management program. J Headache Pain 16:66","journal-title":"J. Headache Pain"},{"issue":"4","key":"651_CR17","first-page":"253","volume":"16","author":"K Oguma","year":"1997","unstructured":"Oguma K, Fujinaga Y, Inoue K (1997) Clostridium Botulinum Toxin. Toxin Rev 16(4):253\u2013266","journal-title":"Toxin Rev."},{"issue":"5","key":"651_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","volume":"82","author":"Y Humeau","year":"2000","unstructured":"Humeau Y, Doussau F, Grant NJ, Poulain B (2000) How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 82(5):427\u2013446","journal-title":"Biochimie"},{"issue":"9","key":"651_CR19","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0041-0101(96)00180-8","volume":"35","author":"LB Pearce","year":"1997","unstructured":"Pearce LB, First ER, Maccallum RD, Gupta A (1997) Pharmacologic characterization of Botulinum toxin for basic science and medicine. Toxicon 35(9):1373\u20131412","journal-title":"Toxicon"},{"issue":"7","key":"651_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"SK Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30(7):793\u2013803","journal-title":"Cephalalgia"},{"issue":"7","key":"651_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"HC Diener","year":"2010","unstructured":"Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30(7):804\u201314","journal-title":"Cephalalgia"},{"key":"651_CR22","doi-asserted-by":"crossref","unstructured":"Micheli F, Scorticati MC, Raina G (2002) Beneficial effects of botulinum toxin type a for patients with painful tic convulsif. Clin Neuropharmacol 25(5):260\u20132. http:\/\/journals.lww.com\/clinicalneuropharm\/Abstract\/2002\/09000\/Beneficial_Effects_of_Botulinum_Toxin_Type_A_for.6.asp","DOI":"10.1097\/00002826-200209000-00006"},{"issue":"6","key":"651_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0333102412441721","volume":"32","author":"C-J Wu","year":"2012","unstructured":"Wu C-J, Lian Y-J, Zheng Y-K, Zhang H-F, Chen Y, Xie N-C, Wang L-J (2012) Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia 32(6):443\u201350","journal-title":"Cephalalgia"},{"key":"651_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1129-2377-15-65","volume":"15","author":"H Zhang","year":"2014","unstructured":"Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C (2014) Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain 15:65","journal-title":"J. Headache Pain"},{"issue":"5","key":"651_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/WNF.0b013e31829cb60e","volume":"36","author":"C Z\u00fa\u00f1iga","year":"2013","unstructured":"Z\u00fa\u00f1iga C, Piedimonte F, D\u00edaz S, Micheli F (2013) Acute Treatment of Trigeminal Neuralgia With Onabotulinum Toxin A. Clin Neuropharmacol 36(5):146\u2013150","journal-title":"Clin. Neuropharmacol."},{"key":"651_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1129-2377-14-92","volume":"14","author":"HS Shehata","year":"2013","unstructured":"Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G (2013) Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain 14:92","journal-title":"J. Headache Pain"},{"issue":"8","key":"651_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1517\/14656561003767449","volume":"11","author":"JM Zakrzewska","year":"2010","unstructured":"Zakrzewska JM (2010) Medical management of trigeminal neuropathic pains. Expert Opin Pharmacother 11(8):1239\u201354","journal-title":"Expert Opin. Pharmacother."},{"issue":"1","key":"651_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.wneu.2010.05.001","volume":"74","author":"AE Bond","year":"2010","unstructured":"Bond AE, Zada G, Gonzalez AA, Hansen C, Giannotta SL (2010) Operative strategies for minimizing hearing loss and other major complications associated with microvascular decompression for trigeminal neuralgia. World Neurosurg 74(1):172\u20137","journal-title":"World Neurosurg."},{"issue":"8","key":"651_CR29","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","volume":"65","author":"EJ Piovesan","year":"2005","unstructured":"Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD (2005) An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 65(8):1306\u20131308","journal-title":"Neurology"},{"issue":"1\u20132","key":"651_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui M, Khanijou S, Rubino J, Aoki KR (2004) Subcutaneous administration of botulinum toxin a reduces formalin-induced pain. Pain 107(1\u20132):125\u2013133","journal-title":"Pain"},{"issue":"2","key":"651_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/pme.12017","volume":"14","author":"L Xiao","year":"2013","unstructured":"Xiao L, Cheng J, Zhuang Y, Qu W, Muir J, Liang H, Zhang D (2013) Botulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain. Pain Med 14(2):276\u201386","journal-title":"Pain Med."},{"key":"651_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","volume":"186","author":"I Matak","year":"2011","unstructured":"Matak I, Bach-Rojecky L, Filipovi\u0107 B, Lackovi\u0107 Z (2011) Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 186:201\u20137","journal-title":"Neuroscience"},{"issue":"2","key":"651_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neuint.2012.05.001","volume":"61","author":"I Matak","year":"2012","unstructured":"Matak I, Riederer P, Lackovi\u0107 Z (2012) Botulinum toxin\u2019s axonal transport from periphery to the spinal cord. Neurochem Int 61(2):236\u20139","journal-title":"Neurochem. Int."},{"key":"651_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s40064-016-2071-2","volume":"5","author":"C Wu","year":"2016","unstructured":"Wu C, Xie N, Lian Y, Xu H, Chen C, Zheng Y, Chen Y, Zhang H (2016) Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia. Springerplus 5:431","journal-title":"Springerplus"},{"issue":"1","key":"651_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1129-2377-14-72","volume":"14","author":"Y Hu","year":"2013","unstructured":"Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, Jin L (2013) Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. J Headache Pain 14(1):72","journal-title":"J. Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-016-0651-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0651-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T13:44:18Z","timestamp":1568123058000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-016-0651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1186\/s10194-016-0651-8","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,5]]},"article-number":"63"}}